Navigation Links
UChicago Celiac Disease Center to host international symposium
Date:7/1/2013

The University of Chicago Celiac Disease Center is hosting the 15th International Celiac Disease Symposium (ICDS) on Sept. 22-25, 2013 in Chicago. The symposium is the largest celiac disease and gluten-related disorders conference in the world. The meeting, which follows the 2011 conference in Oslo, Norway, is the first one being held in the United States since 2006.

The Chicago meeting seeks to address the interests of those affected by celiac disease and gluten-related disorders from physicians, researchers and clinicians to patients, their families and friends. The meeting will bring together the world's top scientists and physicians to discuss the most recent scientific advances in managing and treating celiac disease and gluten-related disorders, while a separate clinical forum will be held to further educate dietitians, clinicians, and patients.

"We are thrilled to be hosting this unique and important gathering and expect groundbreaking research to be unveiled that will directly impact the prevention of and perhaps cure of celiac disease," said Dr. Stefano Guandalini, co-chairman of ICDS 2013 and founder and medical director of the University of Chicago Celiac Disease Center. "The interaction between scientists, clinicians and consumers makes for a robust and interactive forum, unlike any other meeting."

ICDS Chicago will feature two educational tracks:

  • The Scientific Forum is designed for those in active research roles in the area of celiac disease and gluten-related disorders. This is a forum for these researchers and physicians to debate and discuss new theories and data on topics selected by the Scientific Committee.

  • The Clinical Forum is designed for physicians, registered dietitians, physician assistants, nurse practitioners, nurses and those living with celiac disease or non-celiac gluten sensitivity. The program will allow participants to learn about the latest research and scienti
    '/>"/>

Contact: Matt Wood
matthew.wood@uchospitals.edu
773-702-5894
University of Chicago Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Ben-Gurion U. and UChicago research collaboration targets water resource innovations
2. New canary seed is ideal for gluten-free diets in celiac disease
3. Pregnant women with high celiac disease antibodies are at risk for low birth weight babies
4. No clear evidence more gluten in new wheat is responsible for increase in celiac disease
5. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
6. Unexpected discovery of the ways cells move could boost understanding of complex diseases
7. La Jolla Institute discovers new player critical to unleashing T cells against disease
8. Artificial sweetener a potential treatment for Parkinsons disease
9. From autism to diabetes to Parkinsons disease
10. Females fend off gut diseases
11. Lifespan-extending drug given late in life reverses age-related heart disease in mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... April 27, 2015  For more than four decades, ... has been the premier worldwide event for the unmanned ... a must-attend event for any local, national, or trade ... emerging commercial markets and current applications of unmanned technologies. ... this projected $48 billion industry, and how it will ...
(Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
(Date:4/27/2015)... Apr. 27, 2015 Profile Solutions, Inc. (OTC: ... security systems is pleased to announce that Dr ... consultant and member of its scientific advisory board. ... as a thought leader in technology-enhanced learning models. He ... and has published studies and books focused on online ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... of Standards and Technology (NIST) will no longer provide ... mercury thermometer calibration program marks the end of an ... the doors opened in 1901. The closing of the ... with the U.S. Environmental Protection Agency (EPA) and a ...
... French . Clostridium difficile ... and other health care facilities, but no new drugs to ... a large-scale, phase 3 trial conducted by Canadian and U.S. ... existing treatments, demonstrating a 45 percent reduction in recurrences vs. ...
... , This release is available in German . ... and is extremely precise: within a few seconds, a laser beam ... screws, clamps or glues whatsoever. The result is a perfect weld ... or particles flying through the air during welding. What,s more: the ...
Cached Biology News:End of an era: NIST to cease calibrating mercury thermometers 2First new C. difficile drug in a generation superior to existing treatments: Researchers 2Laser welding in the right light 2
(Date:4/28/2015)... COPENHAGEN, Denmark , April 28, 2015  DanDrit ... a biotechnology company developing a vaccine for the treatment ... has signed a final collaboration agreement with GISCAD Foundation, ... digestive tract cancer studies. The collaboration relates ... vaccine, in patients with no evidence of disease (NED) ...
(Date:4/28/2015)... ANN ARBOR, Mich. , April 28, 2015 ... OncoTargets and Therapy today shows that the Paradigm ... FoundationOne test across a number of key clinical variables, ... The purpose of the analysis was to ... for profiling cancer patients compared with each other.  ...
(Date:4/28/2015)... uBiome, Inc. has announced the ... clinical tests based on its unique microbial assays. ... sparked the era of microbiome-based personalized medicine by ... information about their own bodies using the latest ... uBiome has gathered millions of data points in ...
(Date:4/28/2015)... According to a 2013 report from ... medical treatment from burn injuries per year. Despite several ... formation of scars with subsequent contractures remains a major ... there is no adequate treatment. Contractures are a permanent ... can cause permanent deformity. , Synedgen has developed ...
Breaking Biology Technology:DanDrit Biotech USA, Inc. Announces Final Collaboration Agreement with the GISCAD Foundation 2DanDrit Biotech USA, Inc. Announces Final Collaboration Agreement with the GISCAD Foundation 3DanDrit Biotech USA, Inc. Announces Final Collaboration Agreement with the GISCAD Foundation 4Paradigm Cancer Diagnostic Test (PCDx) Performed Better Than FoundationOne In Side by Side Clinical Study 2Paradigm Cancer Diagnostic Test (PCDx) Performed Better Than FoundationOne In Side by Side Clinical Study 3uBiome Launches Clinical Laboratory 2Synedgen Burn Treatment Results Presented at Premier Wound Conference 2Synedgen Burn Treatment Results Presented at Premier Wound Conference 3
... at American Society of Pharmacognosy, EMERYVILLE, Calif., ... will present seminal information on a new drug ... 7th Annual Oxford International,Conference on the Science of ... April 12-16, 2008. Scott Baggett, Ph.D., a member ...
... April 14 Codexis, Inc. announced,today that it has ... U.S.,Securities and Exchange Commission ("SEC") relating to the proposed ... of the Codexis,registration statement on Form S-1 can be ... shares being offered and the price,range for the offering ...
... and reduced cost for ... pharmaceutical manufacturers, NEW YORK, ... agreement with Chiral Quest, Inc., a manufacturer and,developer of chiral ... chiral products to the pharmaceutical industry., Effective immediately, Sumitomo ...
Cached Biology Technology:Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness 2Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness 3Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering 2Sumitomo Corporation of America Named Exclusive Distribution and Sales Agent for Chiral Quest 2
... Neurotransmitters are stored within neurons ... are concentrated in the synaptic bouton. ... isolated from other cellular ... been proposed in many pathological condtions. ...
... CLS number is a ... to easily match Cornings ... no availability yet, please ... Sigma-Aldrich number (Z71,515-8) or ...
... the value of your microarray data ... the support you need from consultation ... most up to date methods. Utilize ... Gene Expression Profiling Service or from ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: ...
Biology Products: